Bpr Pharma Ltd
Market research and public opinion polling
Bpr Pharma Ltd contacts: address, phone, fax, email, website, shedule
Address: 34 Bedford Row WC1R 4JH London
Phone: +44-1269 3911651
Fax: +44-1303 7536865
Email: n\a
Website: n\a
Shedule:
Incorrect data or we want add more details informations for "Bpr Pharma Ltd"? - send email to us!
Registration data Bpr Pharma Ltd
Register date: 2010-11-02
Register number: 07426148
Type of company: Private Limited Company
Get full report form global database UK for Bpr Pharma LtdOwner, director, manager of Bpr Pharma Ltd
Bridget Susan Pumfrey Director. Address: Frithville Gardens, London, W12 7JQ, United Kingdom. DoB: October 1966, British
Bridget Susan Pumfrey Secretary. Address: Frithville Gardens, London, W12 7JQ, United Kingdom. DoB:
Matthew James Brooks Director. Address: Station Road, Long Marston, Tring, Herts, HP23 4QS, United Kingdom. DoB: April 1969, British
Jobs in Bpr Pharma Ltd vacancies. Career and practice on Bpr Pharma Ltd. Working and traineeship
Helpdesk. From GBP 1500
Driver. From GBP 1600
Project Planner. From GBP 2800
Director. From GBP 6400
Driver. From GBP 2100
Welder. From GBP 1400
Electrician. From GBP 1700
Responds for Bpr Pharma Ltd on FaceBook
Read more comments for Bpr Pharma Ltd. Leave a respond Bpr Pharma Ltd in social networks. Bpr Pharma Ltd on Facebook and Google+, LinkedIn, MySpaceAddress Bpr Pharma Ltd on google map
Other similar UK companies as Bpr Pharma Ltd: Tresorelle Limited | Adelp Financial Solutions Ltd | Nest Solutions Limited | Ccl Finance Limited | Clear Start Uk Limited
Based in 34 Bedford Row, London WC1R 4JH Bpr Pharma Ltd is a PLC issued a 07426148 Companies House Reg No.. This company was founded 6 years ago. Bpr Pharma Ltd was registered one year from now under the name of Brooks Pumfrey Research. This enterprise is classified under the NACe and SiC code 73200 , that means Market research and public opinion polling. December 31, 2014 is the last time account status updates were filed. Bpr Pharma Limited has been on the market for the last six years.
Bridget Susan Pumfrey and Matthew James Brooks are listed as firm's directors and have been monitoring progress towards achieving the objectives and policies since 2010-11-02.
